Adial Pharmaceuticals
ADIL
#10837
Rank
โ‚น1.22 B
Marketcap
โ‚น467.98
Share price
36.12%
Change (1 day)
1,641.17%
Change (1 year)

EPS for Adial Pharmaceuticals (ADIL)

EPS in 2026 (TTM): -โ‚น1,779

According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น1,792. In 2025 the company made an earnings per share (EPS) of -โ‚น1,106 an increase over its 2024 EPS that were of -โ‚น6,302.

EPS history for Adial Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น1,77960.92%
2025-โ‚น1,106-82.46%
2024-โ‚น6,302-24.43%
2023-โ‚น8,340-71.68%
2022-โ‚น29,446-51.12%
2021-โ‚น60,23519.54%
2020-โ‚น50,389-0%
2019-โ‚น50,389-64.34%
2018-โ‚น1,41,3221072.27%
2017-โ‚น12,055136.68%
2016-โ‚น5,094-56.33%
2015-โ‚น11,664

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น5.56-99.69% Bahamas
NRC Health
NRC
โ‚น26.87-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA